JJ

Jivnath Jha

Active Director Director DIN 10465859
DIN 10465859 First appointment Jan 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value •••• Premium profile

About Jivnath Jha

Data last updated:

Jivnath Jha is a Director at Orosys Pharma Private Limited (since 2024). The company operates in Pharma. Orosys Pharma Private Limited reported revenue of ₹1.1 Lakh (FY 2025).

DIN 10465859
Primary Designation Director
Industry Pharma
First Appointment 16 Jan 2024
Oldest Company Age 7 yrs
Largest company Orosys Pharma Private Limited · ₹1.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Orosys Pharma Private Limited U51909MP2019PTC049352
Director16 Jan 20242019₹1.1 Lakh (FY 2025)Active

Board colleagues of Jivnath Jha

NameDINCompanyDesignation
Navneet Kumar Singh08539339Orosys Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Orosys Pharma Private Limited
Premium access

Shareholding and investment profile for Jivnath Jha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jivnath Jha

Jivnath Jha currently holds 1 directorship: Orosys Pharma Private Limited (Director, since 16 Jan 2024, revenue ₹1.1 Lakh (FY 2025)).

Jivnath Jha was first appointed on 16 Jan 2024 as Director at Orosys Pharma Private Limited.

The current boards of Jivnath Jha's companies include Navneet Kumar Singh (Orosys Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available